Targeted Preconditioning and Cell Transplantation in the Murine Lower Respiratory Tract
American Journal of Respiratory Cell and Molecular Biology · 2026
DOI: 10.1165/rcmb.2024-0597ma ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Respiratory Cell and Molecular Biology, 2026. Verfasst von Anat Kohn und 6 weiteren Autor:innen. Beteiligte Einrichtung: Center for Regenerative Medicine, Boston University and Boston Medical Center, Boston, Massachusetts. Hauptthemen laut MEDLINE: Stem Cell Transplantation, Trachea. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIH HHS, Cystic Fibrosis Foundation, NHLBI NIH HHS.
Abstract (Originalsprache)
Transplantation of airway basal stem cells could achieve a durable cure for genetic diseases of the airway, such as cystic fibrosis and primary ciliary dyskinesia. Recent work demonstrated the potential of primary and pluripotent stem cell–derived basal cells to efficiently engraft into the mouse trachea after injury. However, there are many hurdles to overcome in translating these approaches to humans, including developing safe and efficient methods for delivery in larger animal models. We propose a model that targets preconditioning and cell delivery to intrapulmonary airways using a microbronchoscope for delivery. The detergent polidocanol was adapted for distal lung preconditioning, inducing intrapulmonary airway epithelial denudation by 5 and 24 hours after delivery. Although initial reepithelialization of airways occurred later than that of tracheas, complete repair was observed within 7 days. Both pluripotent stem cell–derived and primary basal cells delivered via microbronchoscope after polidocanol injury engrafted in tracheas and intrapulmonary airways, respectively. Transplanted cells differentiated into ciliated and secretory lineages while maintaining a population of basal cells. These findings demonstrate the utility of bronchoscopically targeted preconditioning and cell delivery to the conducting intrapulmonary airways, thus providing an important framework for preclinical translation of approaches for engineered airway epithelial regeneration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Regenerative Medicine, Boston University and Boston Medical Center, Boston, Massachusetts.
- The Pulmonary Center, Department of Medicine, Chobanian & Avedisian School of Medicine, Boston University, Boston, Massachusetts.
- Division of Pulmonary, Allergy, Sleep, and Critical Care Medicine, Department of Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania; and.
- Department of Biology, Boston University, Boston, Massachusetts.
ORCID-Profile: Anat Kohn, Michael J Herriges
Förderung
- NIH HHS
- Cystic Fibrosis Foundation
- NHLBI NIH HHS
- Parker B. Francis Foundation Parker B. Francis Fellowship
- Cystic Fibrosis Foundation Therapeutics
- National Institutes of Health
- National Heart, Lung, and Blood Institute
Zitieren
APA
Kohn, A., Herriges, M. J., Basak, P., Ma, L., Thapa, B. R., Kotton, D. N., & Hawkins, F. J. (2026). Targeted Preconditioning and Cell Transplantation in the Murine Lower Respiratory Tract. American Journal of Respiratory Cell and Molecular Biology. https://doi.org/10.1165/rcmb.2024-0597ma
Vancouver
Kohn A, Herriges MJ, Basak P, Ma L, Thapa BR, Kotton DN, et al. Targeted Preconditioning and Cell Transplantation in the Murine Lower Respiratory Tract. American Journal of Respiratory Cell and Molecular Biology. 2026. doi:10.1165/rcmb.2024-0597ma
BibTeX
@article{Kohn2026,
author = {Kohn, Anat and Herriges, Michael J and Basak, Payel and Ma, Liang and Thapa, Bibek R and Kotton, Darrell N and Hawkins, Finn J},
title = {Targeted Preconditioning and Cell Transplantation in the Murine Lower Respiratory Tract},
journal = {American Journal of Respiratory Cell and Molecular Biology},
year = {2026},
doi = {10.1165/rcmb.2024-0597ma}
}
EUVIMED